US76029N1063
US76029N1063
Replimune Group, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.26B EUR | 929.65M EUR | 632.78M EUR | 774.01M EUR |
Enterprise Value | 1.15B EUR | 856.27M EUR | 535.35M EUR | 727.41M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -7.38x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 10.67x | 8.8x | 3.81x | 3.68x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -3.94x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -13.58% | -30.18% | -44.97% | -29.51% |